Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

FDA requires further information for approval of Plenaxis

Sep. 14, 2001

Biomira begins exploratory phase Ib trial of B-cell lymphoma vaccine

Sep. 13, 2001

Asta Medica patents new antitumor agents that act as microtubule destabilizers

Sep. 13, 2001

Clinical benefit of IntraDose not fully demonstrated according to ODAC

Sep. 13, 2001

FDA approves Xeloda/Taxotere combination therapy for metastatic breast cancer

Sep. 13, 2001

Corixa and GSK complete resubmission of Bexxar BLA to FDA

Sep. 13, 2001

New platinum compound licensed by NeoOncoRx, heading for phase III

Sep. 13, 2001

Progenics and Cytogen team up with AlphaVax to develop PSMA ArV vaccine

Sep. 13, 2001

Novuspharma antitumor agents particularly effective against solid tumors

Sep. 12, 2001

Targeted apoptosis research program at Antisoma expanded by newly acquired rights from NIH

Sep. 12, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...